Elfabrio Injection, Solution, Concentrate
Product Images NDC 10122-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Elfabrio (NDC 10122-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 10122-160-02elfabrio(pegunigalsidase Alfa-iwxj)injection20 mg/ 10 mL (2 mg/ml)for Intravenous Infusion After Dilutionrx Only1 X 10 mL Single-dose Vialdiscard Unused Portion. (Elfabrio 01)

Ndc 10122-160-02elfabrio(pegunigalsidase Alfa-iwxj)injection20 mg/ 10 mL (2 mg/ml)for Intravenous Infusion After Dilutionrx Only1 X 10 mL Single-dose Vialdiscard Unused Portion. (Elfabrio 01)
Packaging label for ELFABRIO injection, 20 mg per 10 mL (2 mg/mL) pegunigalsidase alfa solution concentrate. The label includes storage instructions, dosage form as intravenous infusion after dilution, manufacturer Chiesi USA, Inc., and package details indicating a single 10 mL single-dose vial. The label displays dosage strength prominently along with barcodes and trademark information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.